TCM
BMY.RT
Tekla Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,473,710
| Closed | -$1.02M | – | 226 |
|
|
2020
Q4 | $1.02M | Hold |
1,473,710
| – | – | 0.04% | 178 |
|
|
2020
Q3 | $3.32M | Hold |
1,473,710
| – | – | 0.12% | 121 |
|
|
2020
Q2 | $5.28M | Hold |
1,473,710
| – | – | 0.2% | 98 |
|
|
2020
Q1 | $5.6M | Hold |
1,473,710
| – | – | 0.25% | 77 |
|
|
2019
Q4 | $4.44M | Buy |
+1,473,710
| New | +$4.44M | 0.17% | 113 |
|